Maraviroc
A4001056
Phase 2 small_molecule terminated
Quick answer
Maraviroc for Arthritis, Rheumatoid is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Arthritis, Rheumatoid
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated